Large registry analysis to accurately define second malignancy rates and risks in a well-characterized cohort of 744 consecutive multiple myeloma patients followed-up for 25 years.

Large registry analysis to accurately define second malignancy rates and risks in a well-characterized cohort of 744 consecutive multiple myeloma patients followed-up for 25 years.

Item
http://www.wikidata.org/entity/Q36115686
Survival in multiple myeloma patients who develop second malignancies: a population-based cohort studyAutotransplant with and without induction chemotherapy in older multiple myeloma patients: long-term outcome of a randomized trial.Geriatric assessment in multiple myeloma patients: validation of the International Myeloma Working Group (IMWG) score and comparison with other common comorbidity scores.A concise revised Myeloma Comorbidity Index as a valid prognostic instrument in a large cohort of 801 multiple myeloma patients.Secondary malignancies in patients with multiple myeloma, Waldenström macroglobulinemia and monoclonal gammopathy of undetermined significance.Second primary malignancies in multiple myeloma: an overview and IMWG consensus.The serum heavy/light chain immunoassay: A valuable tool for sensitive paraprotein assessment, risk, and disease monitoring in monoclonal gammopathies.Issues in diagnosis of small B cell lymphoid neoplasms involving the bone marrow and peripheral blood. Report on the Bone Marrow Workshop of the XVIIth meeting of the European Association for Haematopathology and the Society for Hematopathology.Clonal plasma cells keep strange company.
P2860

Large registry analysis to accurately define second malignancy rates and risks in a well-characterized cohort of 744 consecutive multiple myeloma patients followed-up for 25 years.

Item
http://www.wikidata.org/entity/Q36115686
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Large registry analysis to acc ...... ents followed-up for 25 years.
@ast
Large registry analysis to acc ...... ents followed-up for 25 years.
@en
type
label
Large registry analysis to acc ...... ents followed-up for 25 years.
@ast
Large registry analysis to acc ...... ents followed-up for 25 years.
@en
prefLabel
Large registry analysis to acc ...... ents followed-up for 25 years.
@ast
Large registry analysis to acc ...... ents followed-up for 25 years.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P932
P356
P1433
P1476
Large registry analysis to acc ...... ents followed-up for 25 years.
@en
P2093
P2860
P304
P31
P356
10.3324/HAEMATOL.2015.127548
P433
P478
P50
P577
P5875
P698
P932